Taiwan Doctors Urge Subsidized Vaccines Against Cervical Cancer
This article was originally published in PharmAsia News
Taiwan physicians are urging the government to subsidize the cost of vaccinating female patients against cervical cancer. Two available vaccines are not covered by the country's National Health Insurance and a complete set of shots costs more than $330, said one obstetrician/gynecologist. His plea came a day after the Department of Health approved the second vaccine for marketing. (Click here for more
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
With Roche's oral spinal muscular atrophy therapy Evrysdi off to a strong start after its recent US launch, Novartis is switching its priorities for rival RNA-splicing drug branaplam and putting it into a Phase IIb trial for Huntington's disease.
Nuvation started in 2018 and raised a $275m series A round in 2019. Now it is merging with the EcoR1 Capital-sponsored SPAC Panacea Acquisition Corp. and raising $500m in equity capital.